...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial
【24h】

Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial

机译:局部复发直肠癌的治疗和存活:荷兰TME试验15年后的横截面群体研究

获取原文
获取原文并翻译 | 示例

摘要

Introduction: Optimized treatment of primary rectal cancer might have influenced treatment characteristics and outcome of locally recurrent rectal cancer (LRRC). Subgroup analysis of the Dutch TME trial showed that preoperative radiotherapy (PRT) for the primary tumour was an independent poor prognostic factor after diagnosis of LRRC. This cross-sectional population study aimed to evaluate treatment and overall survival (OS) of LRRC patients, stratified for prior preoperative radiotherapy (PRT) and intention of treatment of LRRC.
机译:介绍:原发性直肠癌的优化治疗可能会影响局部复发直肠癌(LRRC)的治疗特征和结果。 荷兰TME试验的亚组分析表明,原发性肿瘤的术前放疗(PRT)是诊断LRRC后的独立差的预后因素。 这种横截面群体研究旨在评估LRRC患者的治疗和整体存活(OS),分层为先前的术前放疗(PRT)和LRRC治疗的意图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号